Cannabinoid Receptor Type-2 in B Cells Is Associated with Tumor Immunity in Melanoma.

Gruber, Thomas; Robatel, Steve; Kremenovic, Mirela; Bäriswyl, Lukas; Gertsch, Jürg; Schenk, Mirjam

Gruber, Thomas; Robatel, Steve; Kremenovic, Mirela; Bäriswyl, Lukas; Gertsch, Jürg; Schenk, Mirjam.

Afiliação

Gruber T; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Robatel S; Graduate School GCB, University of Bern, 3012 Bern, Switzerland.
Kremenovic M; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Bäriswyl L; Graduate School GCB, University of Bern, 3012 Bern, Switzerland.
Gertsch J; Institute of Pathology, University of Bern, 3008 Bern, Switzerland.
Schenk M; Graduate School GCB, University of Bern, 3012 Bern, Switzerland.

Cancers (Basel) ; 13(8)2021 Apr 16.

Article em En | MEDLINE | ID: mdl-33923757

Palavras-chave

CB2R; cannabinoid receptor type-2; endocannabinoid system; melanoma; regulatory B cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google